We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · October 21, 2021

Decreased First-Line Therapy in Older Women With HER2+ MBC Is Associated With Worse Outcomes

The Breast


Additional Info

Disclosure statements are available on the authors' profiles:

The Breast
Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database
Breast 2021 Oct 01;[EPub Ahead of Print], M Annonay, L Gauquelin, R Geiss, M Ung, L Cristol-Dalstein, MA Mouret-Reynier, A Goncalves, S Abadie-Lacourtoisie, E Francois, C Perrin, J Le Fel, V Lorgis, V Servent, L Uwer, C Jouannaud, M Leheurteur, F Joly, L Campion, C Courtinard, O Villacroux, T Petit, P Soubeyran, C Terret, C Bellera, E Brain, S Delaloge

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading